BACKGROUND: The ability to predict recovery of left ventricular ejection fraction (LVEF) in response to guideline-directed therapy among patients with nonischemic cardiomyopathy is desired. We sought ...
Codeveloped by the American Heart Association and the American Red Cross, these guidelines represent the first comprehensive ...
BACKGROUND: Many studies have explored whether individual plasma protein biomarkers improve cardiovascular disease risk ...
Kawasaki disease (KD), an acute self-limited febrile illness that primarily affects children <5 years old, is the leading cause of acquired heart disease in developed countries, with the potential of ...
Cardiac resynchronization therapy (CRT) is considered a beneficial and disease-modifying treatment in appropriately selected heart failure (HF) patients. It reduces morbidity and mortality, reverses ...
When a manuscript is ready for submission, please proceed to the manuscript submission site. Those manuscripts that are revised or ultimately accepted will be required to be formatted by the authors ...
Introduction: Seismocardiography (SCG) - measurements of cardiovascular-induced vibrations on the chest - has shown potential for providing clinical information for cardiac conditions. SCG is ...
Introduction: Individuals with type 1 diabetes (T1D) complicated by impaired awareness of hypoglycemia (IAH) are at significantly increased risk for severe hypoglycemia: a marker of high risk of CVD.
Introduction/Background: The American Heart Association’s National Hypertension Control Initiative (NHCI) collaborated with health care professionals and public ...
Introduction: Sarcoidosis is a granulomatous disease that can affect multiple organ systems, including the heart. Cardiac Sarcoidosis (CS) is one of the most severe manifestations. It is characterized ...